Outcomes of Targeted Therapy Plus Immunotherapy and High -Dose Stereotactic Ablative Body Radiotherapy (SABR) for Metastatic Renal Cell Cancer Patients

被引：0
|
作者：
Ma, M. W. [1 ]
Gao, X. S. [1 ]
Li, H. Z. [1 ]
Yang, K. W. [2 ]
Yu, W. [2 ]
He, Z. S. [2 ]
Bai, Y. [1 ]
Chen, J. [1 ]
Wang, Z. S. [3 ]
机构：
[1] Peking Univ First Hosp, Dept Radiat Oncol, Beijing, Peoples R China
[2] Peking Univ First Hosp, Dept Urol, Beijing, Peoples R China
[3] Hebei Yizhou Proton Ctr, Zhuozhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2903
引用
收藏
页码：E412 / E412
页数：1
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [2] The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)
    Moreno-Olmedo, Elena
    Sabharwal, Ami
    Das, Prantik
    Dallas, Nicola
    Ford, Daniel
    Perna, Carla
    Camilleri, Philip
    [J]. CANCERS, 2024, 16 (15)
  • [3] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [4] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [5] Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
    Kroeze, Stephanie G. C.
    Fritz, Corinna
    Schaule, Jana
    Siva, Shankar
    Kahl, Klaus H.
    Sundahl, Nora
    Blanck, Oliver
    Kaul, David
    Adebahr, Sonja
    Verhoeff, Joost J. C.
    Skazikis, Georgios
    Roeder, Falk
    Geier, Michael
    Eckert, Franziska
    Guckenberger, Matthias
    [J]. BJU INTERNATIONAL, 2021, 127 (06) : 703 - 711
  • [6] Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients
    Ma, Ming-Wei
    Li, Hong-Zhen
    Gao, Xian-Shu
    Liu, Ming-Zhu
    Yin, Huan
    Yang, Kai-Wei
    Chen, Jia-Yan
    Ren, Xue-Ying
    Wang, Dian
    [J]. CURRENT ONCOLOGY, 2022, 29 (10) : 7832 - 7841
  • [7] STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) OUTCOMES FOR PRIMARY AND METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PULMONARY TUMOURS
    Thibault, Isabelle
    Poon, Ian
    Erler, Darby
    Kim, Anthony
    Keller, Brian
    Yeung, Latifa
    Jain, Suneil
    Soliman, Hany
    Lochray, Fiona
    Cheung, Patrick
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S837 - S838
  • [8] Outcomes of Multiple/All lesions Stereotactic Ablative Radiation Therapy (SABR) for Oligo-Metastatic Renal Cancer
    Ma, M. W.
    Liu, M. Z.
    Li, H. Z.
    Gao, X. S.
    Yin, H.
    Yang, K. W.
    Wang, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E208 - E208
  • [9] Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
    Groves, Jonathan
    Yeo, Ryan
    Tsang, Yat
    Shah, Nihal
    Win, Thida
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [10] Evaluating dose coverage and conformity in stereotactic ablative body radiotherapy (SABR) plans
    O'Keeffe, Serena
    Fleming, Cathy
    Vintro, Luis Leon
    Mcclean, Brendan
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2024, 118
12345